0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Blood Glucose Lancets Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-25P7844
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Blood Glucose Lancets Market Insights and Forecast to 2028
BUY CHAPTERS

Global Blood Glucose Lancets Market Research Report 2025

Code: QYRE-Auto-25P7844
Report
August 2025
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Glucose Lancets Market Size

The global market for Blood Glucose Lancets was valued at US$ 1201 million in the year 2024 and is projected to reach a revised size of US$ 1603 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Blood Glucose Lancets Market

Blood Glucose Lancets Market

Blood glucose lancets are small, sterile devices with a sharp tip used to pierce the skin, typically the fingertip, to collect a blood sample for measuring glucose levels. They are commonly used by people with diabetes as part of their daily routine to monitor blood sugar levels. Lancets are usually disposable and designed to minimize pain during the blood sampling process. They come in various sizes and needle gauges to accommodate different levels of skin sensitivity.
Market Drivers:
Rising prevalence of diabetes: The global surge in diabetes cases, fueled by lifestyle changes, poor diets, and increasing obesity, has led to higher demand for blood sugar monitoring devices, including lancets.
Increased awareness about diabetes management: Governments and healthcare organizations are focusing on awareness campaigns about the importance of regular blood sugar monitoring, which boosts demand for self-monitoring devices and lancets.
Technological advancements: Continuous innovations in lancet design, such as painless, ultra-thin, and easy-to-use lancets, are attracting consumers who prefer comfortable and convenient blood sugar testing methods.
Aging population: Older adults are more prone to diabetes and require frequent blood sugar monitoring, thereby increasing the demand for lancets in healthcare settings.
Home healthcare trend: The growing preference for home-based healthcare and self-monitoring tools has led to a rise in the use of personal blood glucose monitoring systems, including lancets.
Increase in health expenditures: Higher healthcare spending by both individuals and governments is propelling the growth of diabetes-related products, especially in developing countries.
Market Challenges:
Risk of infections: Improper use of lancets or reusing them can lead to infections, which may deter some individuals from using these devices consistently.
Cost pressures: Lancet devices are often seen as a recurring expense for diabetes patients, which can be a financial burden, especially in low-income countries. This may limit market growth among economically disadvantaged populations.
Availability of alternatives: The development of non-invasive blood glucose monitoring systems (e.g., sensor-based or continuous glucose monitors) is a potential threat to lancet usage, as they reduce the need for frequent finger-pricking.
Regulatory hurdles: Stringent regulations and the need for approvals from healthcare authorities can slow down the launch of new and improved lancet technologies, limiting the pace of market growth.
Environmental concerns: Lancets are generally single-use items, and their disposal raises concerns about medical waste and environmental impact, which may affect their adoption if eco-friendliness becomes a critical factor for consumers or policymakers.
The classification of Blood Glucose Lancets includes Ordinary Lancets and Safety Lancets. In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market. With several hospitals and healthcare facilities converting to safety lancets, this market share is poised for declined. Americas is the largest consumption place, with a consumption market share nearly 40.77% in 2022. Following Americas, Europe is the second largest consumption place with the consumption market share of 30.34%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Glucose Lancets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Glucose Lancets.
The Blood Glucose Lancets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Glucose Lancets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Glucose Lancets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Blood Glucose Lancets Market Report

Report Metric Details
Report Name Blood Glucose Lancets Market
Accounted market size in year US$ 1201 million
Forecasted market size in 2031 US$ 1603 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Safety Lancets
  • Ordinary Lancets
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Cardinal Health, ICU Medical, Sarstedt, Sinocare, Yicheng, Yuwell, Greiner Bio One
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Blood Glucose Lancets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Blood Glucose Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Blood Glucose Lancets Market growing?

Ans: The Blood Glucose Lancets Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Blood Glucose Lancets Market size in 2031?

Ans: The Blood Glucose Lancets Market size in 2031 will be US$ 1603 million.

What is the Blood Glucose Lancets Market share by type?

Ans: In 2023, Ordinary Lancets accounted for a share of 61.81% in the global Lancets market.

What is the Blood Glucose Lancets Market share by region?

Ans: Americas is the largest consumption place, with a consumption market share nearly 40.77% in 2022.

Who are the main players in the Blood Glucose Lancets Market report?

Ans: The main players in the Blood Glucose Lancets Market are Roche, Lifescan, BD, Ascensia, Abbott, B. Braun, ARKRAY, Terumo, I-SENS, Nipro, Cardinal Health, ICU Medical, Sarstedt, Sinocare, Yicheng, Yuwell, Greiner Bio One

What are the Application segmentation covered in the Blood Glucose Lancets Market report?

Ans: The Applications covered in the Blood Glucose Lancets Market report are Hospitals, Homecare, Other

What are the Type segmentation covered in the Blood Glucose Lancets Market report?

Ans: The Types covered in the Blood Glucose Lancets Market report are Safety Lancets, Ordinary Lancets

Recommended Reports

Diabetes Monitoring

Lancets & Accessories

Alternative Monitoring

1 Blood Glucose Lancets Market Overview
1.1 Product Definition
1.2 Blood Glucose Lancets by Type
1.2.1 Global Blood Glucose Lancets Market Value Comparison by Type (2024 VS 2031)
1.2.2 Safety Lancets
1.2.3 Ordinary Lancets
1.3 Blood Glucose Lancets by Application
1.3.1 Global Blood Glucose Lancets Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Homecare
1.3.4 Other
1.4 Global Blood Glucose Lancets Market Size Estimates and Forecasts
1.4.1 Global Blood Glucose Lancets Revenue 2020-2031
1.4.2 Global Blood Glucose Lancets Sales 2020-2031
1.4.3 Global Blood Glucose Lancets Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Blood Glucose Lancets Market Competition by Manufacturers
2.1 Global Blood Glucose Lancets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Blood Glucose Lancets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Blood Glucose Lancets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Blood Glucose Lancets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blood Glucose Lancets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blood Glucose Lancets, Product Type & Application
2.7 Global Key Manufacturers of Blood Glucose Lancets, Date of Enter into This Industry
2.8 Global Blood Glucose Lancets Market Competitive Situation and Trends
2.8.1 Global Blood Glucose Lancets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Blood Glucose Lancets Players Market Share by Revenue
2.8.3 Global Blood Glucose Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Blood Glucose Lancets Market Scenario by Region
3.1 Global Blood Glucose Lancets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Blood Glucose Lancets Sales by Region: 2020-2031
3.2.1 Global Blood Glucose Lancets Sales by Region: 2020-2025
3.2.2 Global Blood Glucose Lancets Sales by Region: 2026-2031
3.3 Global Blood Glucose Lancets Revenue by Region: 2020-2031
3.3.1 Global Blood Glucose Lancets Revenue by Region: 2020-2025
3.3.2 Global Blood Glucose Lancets Revenue by Region: 2026-2031
3.4 North America Blood Glucose Lancets Market Facts & Figures by Country
3.4.1 North America Blood Glucose Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Blood Glucose Lancets Sales by Country (2020-2031)
3.4.3 North America Blood Glucose Lancets Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Blood Glucose Lancets Market Facts & Figures by Country
3.5.1 Europe Blood Glucose Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Blood Glucose Lancets Sales by Country (2020-2031)
3.5.3 Europe Blood Glucose Lancets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blood Glucose Lancets Market Facts & Figures by Region
3.6.1 Asia Pacific Blood Glucose Lancets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Blood Glucose Lancets Sales by Region (2020-2031)
3.6.3 Asia Pacific Blood Glucose Lancets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Blood Glucose Lancets Market Facts & Figures by Country
3.7.1 Latin America Blood Glucose Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Blood Glucose Lancets Sales by Country (2020-2031)
3.7.3 Latin America Blood Glucose Lancets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blood Glucose Lancets Market Facts & Figures by Country
3.8.1 Middle East and Africa Blood Glucose Lancets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Blood Glucose Lancets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Blood Glucose Lancets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Blood Glucose Lancets Sales by Type (2020-2031)
4.1.1 Global Blood Glucose Lancets Sales by Type (2020-2025)
4.1.2 Global Blood Glucose Lancets Sales by Type (2026-2031)
4.1.3 Global Blood Glucose Lancets Sales Market Share by Type (2020-2031)
4.2 Global Blood Glucose Lancets Revenue by Type (2020-2031)
4.2.1 Global Blood Glucose Lancets Revenue by Type (2020-2025)
4.2.2 Global Blood Glucose Lancets Revenue by Type (2026-2031)
4.2.3 Global Blood Glucose Lancets Revenue Market Share by Type (2020-2031)
4.3 Global Blood Glucose Lancets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Blood Glucose Lancets Sales by Application (2020-2031)
5.1.1 Global Blood Glucose Lancets Sales by Application (2020-2025)
5.1.2 Global Blood Glucose Lancets Sales by Application (2026-2031)
5.1.3 Global Blood Glucose Lancets Sales Market Share by Application (2020-2031)
5.2 Global Blood Glucose Lancets Revenue by Application (2020-2031)
5.2.1 Global Blood Glucose Lancets Revenue by Application (2020-2025)
5.2.2 Global Blood Glucose Lancets Revenue by Application (2026-2031)
5.2.3 Global Blood Glucose Lancets Revenue Market Share by Application (2020-2031)
5.3 Global Blood Glucose Lancets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Blood Glucose Lancets Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Lifescan
6.2.1 Lifescan Company Information
6.2.2 Lifescan Description and Business Overview
6.2.3 Lifescan Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lifescan Blood Glucose Lancets Product Portfolio
6.2.5 Lifescan Recent Developments/Updates
6.3 BD
6.3.1 BD Company Information
6.3.2 BD Description and Business Overview
6.3.3 BD Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BD Blood Glucose Lancets Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Company Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ascensia Blood Glucose Lancets Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Company Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Abbott Blood Glucose Lancets Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Company Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.6.4 B. Braun Blood Glucose Lancets Product Portfolio
6.6.5 B. Braun Recent Developments/Updates
6.7 ARKRAY
6.7.1 ARKRAY Company Information
6.7.2 ARKRAY Description and Business Overview
6.7.3 ARKRAY Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.7.4 ARKRAY Blood Glucose Lancets Product Portfolio
6.7.5 ARKRAY Recent Developments/Updates
6.8 Terumo
6.8.1 Terumo Company Information
6.8.2 Terumo Description and Business Overview
6.8.3 Terumo Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Terumo Blood Glucose Lancets Product Portfolio
6.8.5 Terumo Recent Developments/Updates
6.9 I-SENS
6.9.1 I-SENS Company Information
6.9.2 I-SENS Description and Business Overview
6.9.3 I-SENS Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.9.4 I-SENS Blood Glucose Lancets Product Portfolio
6.9.5 I-SENS Recent Developments/Updates
6.10 Nipro
6.10.1 Nipro Company Information
6.10.2 Nipro Description and Business Overview
6.10.3 Nipro Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Nipro Blood Glucose Lancets Product Portfolio
6.10.5 Nipro Recent Developments/Updates
6.11 Cardinal Health
6.11.1 Cardinal Health Company Information
6.11.2 Cardinal Health Description and Business Overview
6.11.3 Cardinal Health Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Cardinal Health Blood Glucose Lancets Product Portfolio
6.11.5 Cardinal Health Recent Developments/Updates
6.12 ICU Medical
6.12.1 ICU Medical Company Information
6.12.2 ICU Medical Description and Business Overview
6.12.3 ICU Medical Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ICU Medical Blood Glucose Lancets Product Portfolio
6.12.5 ICU Medical Recent Developments/Updates
6.13 Sarstedt
6.13.1 Sarstedt Company Information
6.13.2 Sarstedt Description and Business Overview
6.13.3 Sarstedt Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Sarstedt Blood Glucose Lancets Product Portfolio
6.13.5 Sarstedt Recent Developments/Updates
6.14 Sinocare
6.14.1 Sinocare Company Information
6.14.2 Sinocare Description and Business Overview
6.14.3 Sinocare Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sinocare Blood Glucose Lancets Product Portfolio
6.14.5 Sinocare Recent Developments/Updates
6.15 Yicheng
6.15.1 Yicheng Company Information
6.15.2 Yicheng Description and Business Overview
6.15.3 Yicheng Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Yicheng Blood Glucose Lancets Product Portfolio
6.15.5 Yicheng Recent Developments/Updates
6.16 Yuwell
6.16.1 Yuwell Company Information
6.16.2 Yuwell Description and Business Overview
6.16.3 Yuwell Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Yuwell Blood Glucose Lancets Product Portfolio
6.16.5 Yuwell Recent Developments/Updates
6.17 Greiner Bio One
6.17.1 Greiner Bio One Company Information
6.17.2 Greiner Bio One Description and Business Overview
6.17.3 Greiner Bio One Blood Glucose Lancets Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Greiner Bio One Blood Glucose Lancets Product Portfolio
6.17.5 Greiner Bio One Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blood Glucose Lancets Industry Chain Analysis
7.2 Blood Glucose Lancets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blood Glucose Lancets Production Mode & Process Analysis
7.4 Blood Glucose Lancets Sales and Marketing
7.4.1 Blood Glucose Lancets Sales Channels
7.4.2 Blood Glucose Lancets Distributors
7.5 Blood Glucose Lancets Customer Analysis
8 Blood Glucose Lancets Market Dynamics
8.1 Blood Glucose Lancets Industry Trends
8.2 Blood Glucose Lancets Market Drivers
8.3 Blood Glucose Lancets Market Challenges
8.4 Blood Glucose Lancets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Blood Glucose Lancets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Blood Glucose Lancets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Blood Glucose Lancets Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Blood Glucose Lancets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Blood Glucose Lancets Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Blood Glucose Lancets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Blood Glucose Lancets Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Blood Glucose Lancets Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Blood Glucose Lancets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Blood Glucose Lancets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Blood Glucose Lancets, Product Type & Application
 Table 12. Global Key Manufacturers of Blood Glucose Lancets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Blood Glucose Lancets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Glucose Lancets as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Blood Glucose Lancets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Blood Glucose Lancets Sales by Region (2020-2025) & (K Units)
 Table 18. Global Blood Glucose Lancets Sales Market Share by Region (2020-2025)
 Table 19. Global Blood Glucose Lancets Sales by Region (2026-2031) & (K Units)
 Table 20. Global Blood Glucose Lancets Sales Market Share by Region (2026-2031)
 Table 21. Global Blood Glucose Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Blood Glucose Lancets Revenue Market Share by Region (2020-2025)
 Table 23. Global Blood Glucose Lancets Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Blood Glucose Lancets Revenue Market Share by Region (2026-2031)
 Table 25. North America Blood Glucose Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Blood Glucose Lancets Sales by Country (2020-2025) & (K Units)
 Table 27. North America Blood Glucose Lancets Sales by Country (2026-2031) & (K Units)
 Table 28. North America Blood Glucose Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Blood Glucose Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Blood Glucose Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Blood Glucose Lancets Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Blood Glucose Lancets Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Blood Glucose Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Blood Glucose Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Blood Glucose Lancets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Blood Glucose Lancets Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Blood Glucose Lancets Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Blood Glucose Lancets Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Blood Glucose Lancets Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Blood Glucose Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Blood Glucose Lancets Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Blood Glucose Lancets Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Blood Glucose Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Blood Glucose Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Blood Glucose Lancets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Blood Glucose Lancets Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Blood Glucose Lancets Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Blood Glucose Lancets Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Blood Glucose Lancets Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Blood Glucose Lancets Sales (K Units) by Type (2020-2025)
 Table 51. Global Blood Glucose Lancets Sales (K Units) by Type (2026-2031)
 Table 52. Global Blood Glucose Lancets Sales Market Share by Type (2020-2025)
 Table 53. Global Blood Glucose Lancets Sales Market Share by Type (2026-2031)
 Table 54. Global Blood Glucose Lancets Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Blood Glucose Lancets Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Blood Glucose Lancets Revenue Market Share by Type (2020-2025)
 Table 57. Global Blood Glucose Lancets Revenue Market Share by Type (2026-2031)
 Table 58. Global Blood Glucose Lancets Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Blood Glucose Lancets Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Blood Glucose Lancets Sales (K Units) by Application (2020-2025)
 Table 61. Global Blood Glucose Lancets Sales (K Units) by Application (2026-2031)
 Table 62. Global Blood Glucose Lancets Sales Market Share by Application (2020-2025)
 Table 63. Global Blood Glucose Lancets Sales Market Share by Application (2026-2031)
 Table 64. Global Blood Glucose Lancets Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Blood Glucose Lancets Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Blood Glucose Lancets Revenue Market Share by Application (2020-2025)
 Table 67. Global Blood Glucose Lancets Revenue Market Share by Application (2026-2031)
 Table 68. Global Blood Glucose Lancets Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Blood Glucose Lancets Price (USD/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Blood Glucose Lancets Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Lifescan Company Information
 Table 76. Lifescan Description and Business Overview
 Table 77. Lifescan Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Lifescan Blood Glucose Lancets Product
 Table 79. Lifescan Recent Developments/Updates
 Table 80. BD Company Information
 Table 81. BD Description and Business Overview
 Table 82. BD Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. BD Blood Glucose Lancets Product
 Table 84. BD Recent Developments/Updates
 Table 85. Ascensia Company Information
 Table 86. Ascensia Description and Business Overview
 Table 87. Ascensia Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Ascensia Blood Glucose Lancets Product
 Table 89. Ascensia Recent Developments/Updates
 Table 90. Abbott Company Information
 Table 91. Abbott Description and Business Overview
 Table 92. Abbott Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Abbott Blood Glucose Lancets Product
 Table 94. Abbott Recent Developments/Updates
 Table 95. B. Braun Company Information
 Table 96. B. Braun Description and Business Overview
 Table 97. B. Braun Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. B. Braun Blood Glucose Lancets Product
 Table 99. B. Braun Recent Developments/Updates
 Table 100. ARKRAY Company Information
 Table 101. ARKRAY Description and Business Overview
 Table 102. ARKRAY Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. ARKRAY Blood Glucose Lancets Product
 Table 104. ARKRAY Recent Developments/Updates
 Table 105. Terumo Company Information
 Table 106. Terumo Description and Business Overview
 Table 107. Terumo Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Terumo Blood Glucose Lancets Product
 Table 109. Terumo Recent Developments/Updates
 Table 110. I-SENS Company Information
 Table 111. I-SENS Description and Business Overview
 Table 112. I-SENS Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. I-SENS Blood Glucose Lancets Product
 Table 114. I-SENS Recent Developments/Updates
 Table 115. Nipro Company Information
 Table 116. Nipro Description and Business Overview
 Table 117. Nipro Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Nipro Blood Glucose Lancets Product
 Table 119. Nipro Recent Developments/Updates
 Table 120. Cardinal Health Company Information
 Table 121. Cardinal Health Description and Business Overview
 Table 122. Cardinal Health Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Cardinal Health Blood Glucose Lancets Product
 Table 124. Cardinal Health Recent Developments/Updates
 Table 125. ICU Medical Company Information
 Table 126. ICU Medical Description and Business Overview
 Table 127. ICU Medical Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. ICU Medical Blood Glucose Lancets Product
 Table 129. ICU Medical Recent Developments/Updates
 Table 130. Sarstedt Company Information
 Table 131. Sarstedt Description and Business Overview
 Table 132. Sarstedt Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Sarstedt Blood Glucose Lancets Product
 Table 134. Sarstedt Recent Developments/Updates
 Table 135. Sinocare Company Information
 Table 136. Sinocare Description and Business Overview
 Table 137. Sinocare Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Sinocare Blood Glucose Lancets Product
 Table 139. Sinocare Recent Developments/Updates
 Table 140. Yicheng Company Information
 Table 141. Yicheng Description and Business Overview
 Table 142. Yicheng Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Yicheng Blood Glucose Lancets Product
 Table 144. Yicheng Recent Developments/Updates
 Table 145. Yuwell Company Information
 Table 146. Yuwell Description and Business Overview
 Table 147. Yuwell Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Yuwell Blood Glucose Lancets Product
 Table 149. Yuwell Recent Developments/Updates
 Table 150. Greiner Bio One Company Information
 Table 151. Greiner Bio One Description and Business Overview
 Table 152. Greiner Bio One Blood Glucose Lancets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Greiner Bio One Blood Glucose Lancets Product
 Table 154. Greiner Bio One Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Blood Glucose Lancets Distributors List
 Table 158. Blood Glucose Lancets Customers List
 Table 159. Blood Glucose Lancets Market Trends
 Table 160. Blood Glucose Lancets Market Drivers
 Table 161. Blood Glucose Lancets Market Challenges
 Table 162. Blood Glucose Lancets Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Blood Glucose Lancets
 Figure 2. Global Blood Glucose Lancets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Blood Glucose Lancets Market Share by Type: 2024 & 2031
 Figure 4. Safety Lancets Product Picture
 Figure 5. Ordinary Lancets Product Picture
 Figure 6. Global Blood Glucose Lancets Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Blood Glucose Lancets Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Homecare
 Figure 10. Other
 Figure 11. Global Blood Glucose Lancets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Blood Glucose Lancets Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Blood Glucose Lancets Sales (2020-2031) & (K Units)
 Figure 14. Global Blood Glucose Lancets Average Price (USD/Unit) & (2020-2031)
 Figure 15. Blood Glucose Lancets Report Years Considered
 Figure 16. Blood Glucose Lancets Sales Share by Manufacturers in 2024
 Figure 17. Global Blood Glucose Lancets Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Blood Glucose Lancets Players: Market Share by Revenue in Blood Glucose Lancets in 2024
 Figure 19. Blood Glucose Lancets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Blood Glucose Lancets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Blood Glucose Lancets Sales Market Share by Country (2020-2031)
 Figure 22. North America Blood Glucose Lancets Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Blood Glucose Lancets Sales Market Share by Country (2020-2031)
 Figure 26. Europe Blood Glucose Lancets Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Blood Glucose Lancets Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Blood Glucose Lancets Revenue Market Share by Region (2020-2031)
 Figure 34. China Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Blood Glucose Lancets Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Blood Glucose Lancets Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Blood Glucose Lancets Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Blood Glucose Lancets Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Blood Glucose Lancets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Blood Glucose Lancets by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Blood Glucose Lancets by Type (2020-2031)
 Figure 56. Global Blood Glucose Lancets Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Blood Glucose Lancets by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Blood Glucose Lancets by Application (2020-2031)
 Figure 59. Global Blood Glucose Lancets Price (USD/Unit) by Application (2020-2031)
 Figure 60. Blood Glucose Lancets Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India